Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade in Palmoplantar Psoriasis
NCT00629772Phase 3Completed
- Sponsor
- Innovaderm Research
- Start
- Mar 2007
- Primary completion
- Feb 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in palmoplantar psoriasis, sponsored by Innovaderm Research. Started Mar 2007; status: completed.
02
Drugs
infliximab
03
Conditions
palmoplantar psoriasis
Beyond the preview
Go deeper on NCT00629772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629772.